Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2005
11/16/2005CN1227241C Arylpiperazines having activity at the serotnin 1A receptor
11/16/2005CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes
11/16/2005CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
11/16/2005CN1227029C Combination of hypertension converting enzyme inhibitor with a diuretic for treating microcirculation disorders
11/16/2005CN1227025C Improved methods for processing activated protein C
11/16/2005CN1227024C Chinese traditional medicine for preventing and treating cardiac and cerebral vascular diseases and its preparation
11/16/2005CN1227023C Drug for treating coronary heart disease, angina and preparation method
11/16/2005CN1227013C Application of dwarf lilyturf extract polysaccharide in preparation of myocardial ischemia resistant medicine
11/16/2005CN1227004C Partial fatty acid oxidation inhibitors in treatment of congestive heart failure
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis
11/15/2005US6964984 Preventing desensitization of receptors
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964977 E.g., 5-(((Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-amino)-1,3-dihydro-2H -benzimidazol-2-one; inhibition or antagonism of protein kinases; treating pain or cancer
11/15/2005US6964975 Isoxazole and thiazole compounds and use thereof as medicine
11/15/2005US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors
11/15/2005US6964972 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/15/2005US6964971 Oral administering; sustained release
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964962 A norepinephrine reuptake inhibitor or its salt and a neuroleptic agent
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/15/2005US6964955 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
11/15/2005US6964950 Oligonucleotides which hybridize with nucleic acids which encode said protein; gene therapy; genetic engineering; for treatment of angina and myocardial infarction
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005CA2433190C Amlodipine hemimaleate
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2357833C Treatment of pulmonary hypertension using vasopressin antagonist
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/15/2005CA2296637C Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containingit
11/15/2005CA2207627C 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2130031C Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2111512C 3,5-substituted aminobenzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
11/10/2005WO2005106459A1 Method of determining ability of drug to bind to troponin i and test drug for the determination
11/10/2005WO2005105997A1 Connexin 40 tissue specific gene mutations
11/10/2005WO2005105793A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
11/10/2005WO2005105787A1 Rapid and robust 3d/3d registration technique
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105722A1 Crystal comprising (2r)-2-propyloctoic acid and amine
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity
11/10/2005WO2005105108A1 The use of timosaponin bii in preparing the drug or produce of preventing and treating stroke
11/10/2005WO2005002672A3 Sirt1 modulators for manipulating cells/organism lifespan/stress response
11/10/2005WO2004069142A8 Anti-candida agents for the treatment of prion diseases
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/10/2005US20050250834 11-(Aminoalkyl)isoindolo[2,1-a]indol-6-ones: 11-(2-Dimethylaminoethyl)-2-fluoroisoindolo[2,1-a]indol-6-one; psychological disorders, drug abuse, sleep disorders, Alzheimer's, Parkinson's and Huntington's disease, Irritable bowel syndrome, chemotherapy induced emesis, spinal trauma and/or head injury
11/10/2005US20050250832 For increasing blood-brain barrier permeability
11/10/2005US20050250831 Peroxisome proliferator activated receptor modulators
11/10/2005US20050250827 Preparation of candesartan cilexetil in high purity
11/10/2005US20050250825 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250777 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
11/10/2005US20050250771 Substituted indoles and their use as integrin antagonists
11/10/2005US20050250760 1-[(Indol-3-yl)carbonyl]piperazine derivatives
11/10/2005US20050250715 Remedy
11/10/2005US20050250701 Method of treating the syndrome of coronary heart disease risk factors in humans
11/10/2005US20050250693 Metalloproteinase inhibitors
11/10/2005US20050250672 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents
11/10/2005US20050250203 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
11/10/2005US20050250160 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/10/2005US20050249717 Use of hyaluronidase for preventing and treating cardio vascular diseases
11/10/2005US20050249715 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
11/10/2005US20050249670 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
11/10/2005US20050249664 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis
11/10/2005US20050249663 Coadministration of transport protein with conjugated cobalamin to deliver agents
11/10/2005US20050249398 Rapid and robust 3D/3D registration technique
11/10/2005CA2568436A1 Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor
11/10/2005CA2565024A1 Therapeutic agent for left ventricular diastolic dysfunction
11/10/2005CA2564303A1 Novel pyrrole derivatives with angiotensin ii antagonist activity
11/10/2005CA2563963A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
11/10/2005CA2562297A1 Administration of enoxaparin sodium to patients 75 years and older with st-segment elevation myocardial infarction
11/10/2005CA2560165A1 Solid pharmaceutical form comprising an ltb4 antagonist
11/09/2005EP1593682A2 Derivatives of 4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides, process for their preparation and pharmaceutical compositions thereof
11/09/2005EP1593681A1 Tricyclic compound, process for producing the same, and use
11/09/2005EP1593680A1 Fused-ring pyridine derivative, process for producing the same, and use
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593673A1 Acrylamide derivative, process for producing the same, and use
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1592669A2 Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
11/09/2005EP1592668A1 Crystalline forms of pitavastatin calcium
11/09/2005EP1592660A1 Acylated aminopropanediols and analogues and therapeutic uses thereof
11/09/2005EP1592418A2 Use in therapy of endocannabinoid-like compounds
11/09/2005EP1592383A2 Methods for reducing mortality associated with acute myocardial infarction
11/09/2005EP1549334A4 A pharmaceutical composition comprising a retro-iverso isomer pettide
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1480983B1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
11/09/2005EP1480981B1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
11/09/2005EP1456202B1 Benzothiazoles
11/09/2005EP1411935A4 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
1 ... 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 ... 1595